Checkpoint Therapeutics, Inc. (CKPT): Price and Financial Metrics

Checkpoint Therapeutics, Inc. (CKPT)

Today's Latest Price: $3.15 USD

0.27 (-7.89%)

Updated Jan 27 4:00pm

Add CKPT to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

CKPT Stock Summary

  • For CKPT, its debt to operating expenses ratio is greater than that reported by merely 0.52% of US equities we're observing.
  • CKPT's price/sales ratio is 217.58; that's higher than the P/S ratio of 97.62% of US stocks.
  • As for revenue growth, note that CKPT's revenue has grown -77.36% over the past 12 months; that beats the revenue growth of merely 1.96% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Checkpoint Therapeutics Inc are ZGNX, DCPH, LPTX, CAPR, and SRRK.
  • CKPT's SEC filings can be seen here. And to visit Checkpoint Therapeutics Inc's official web site, go to

CKPT Stock Price Chart Interactive Chart >

Price chart for CKPT

CKPT Price/Volume Stats

Current price $3.15 52-week high $4.50
Prev. close $3.42 52-week low $1.05
Day low $3.06 Volume 979,321
Day high $3.53 Avg. volume 1,099,365
50-day MA $2.75 Dividend yield N/A
200-day MA $2.37 Market Cap 213.83M

Checkpoint Therapeutics, Inc. (CKPT) Company Bio

Checkpoint Therapeutics, Inc., an immuno-oncology biopharmaceutical company, focuses on the acquisition, development, and commercialization of non-chemotherapy and immune-enhanced combination treatments for patients with solid tumor cancers. The company was founded in 2014 and is based in New York, New York. Checkpoint Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.

CKPT Latest News Stream

Event/Time News Detail
Loading, please wait...

CKPT Latest Social Stream

Loading social stream, please wait...

View Full CKPT Social Stream

Latest CKPT News From Around the Web

Below are the latest news stories about Checkpoint Therapeutics Inc that investors may wish to consider to help them evaluate CKPT as an investment opportunity.

Checkpoint Therapeutics initiated at Cantor with Overweight

Checkpoint Therapeutics ([[CKPT]] +8.2%) was initiated at Cantor Fitzgerald with an Overweight rating, PT $16.Analyst Jennifer Kim believes that the potential peak sales opportunity for cosibelimab is underappreciated.Quick look at pipeline:Analyst believes upwards earnings estimate revisions will drive Checkpoint shares higher. Further, she thinks the company's "unique" pricing strategy for...

Seeking Alpha | January 20, 2021

Checkpoint Therapeutics (CKPT) Investor Presentation - Slideshow

The following slide deck was published by Checkpoint Therapeutics, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | January 20, 2021

Checkpoint Therapeutics to Participate in Three January 2021 Virtual Investor Conferences

NEW YORK, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted…

GlobeNewswire | January 6, 2021

Immune Check Activators Market: Growing Trade Among Emerging Economies Opening New Opportunities (2020-2027) | Genentech, Bristol-Myers Squibb, Checkpoint Therapeutics, Inc., GlaxoSmithKline Pharmaceuticals, Hoffmann-La Roche

Latest released the research study on Global Immune Check Activators Market, offers a detailed overview of the factors influencing the global business scope. Immune Check Activators Market research report shows the latest market insights, current situation analysis with upcoming trends

OpenPR | October 16, 2020

How Much Did Checkpoint Therapeutics'(NASDAQ:CKPT) Shareholders Earn From Share Price Movements Over The Last Three Years?

It is a pleasure to report that the Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) is up 57% in the last quarter. But...

Yahoo | September 19, 2020

Read More 'CKPT' Stories Here

CKPT Price Returns

1-mo 12.50%
3-mo 33.47%
6-mo 40.00%
1-year 64.92%
3-year -30.00%
5-year N/A
YTD 18.87%
2020 54.07%
2019 -5.49%
2018 -53.09%
2017 N/A
2016 N/A

Continue Researching CKPT

Here are a few links from around the web to help you further your research on Checkpoint Therapeutics Inc's stock as an investment opportunity:

Checkpoint Therapeutics Inc (CKPT) Stock Price | Nasdaq
Checkpoint Therapeutics Inc (CKPT) Stock Quote, History and News - Yahoo Finance
Checkpoint Therapeutics Inc (CKPT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.811 seconds.